Milton McColl , MD

CEO

Gauss Sugical
Cupertino, CA

CEO and Member Board of Directors Gauss Surgical, Inc.

Milt McColl joined the board of Gauss in the summer of 2011. At the time he had been working closely with the company's founders during the spring of 2011 while he was mentoring students during the 2011 Spring Stanford Biodesign course. Prior to that, starting in April 2007, Milt was a Venture Partner with New Leaf Venture Partners (NLVP). NLVP managed over a billion dollars in Life Science investments and Milt's focus was investing in medical device companies. While at NLVP, Milt lead investments and served on the board of Illuminoss and Glumetrics. For four years he also served on the board of Interlace which was sold to Hologics in January 2011. Milt left NLVP in June of 2011.

Prior to joining New Leaf, Milt was President of the Neurovascular Division of Boston Scientific Corporation (BSC). Milt initially joined BSC in 2001 following the acquisition of Embolic Protection, Inc (EPI) where he served as Vice President and General Manager for the Embolic Protection Franchise, part of the Interventional Cardiology division of BSC. Milt joined EPI in 2000 as one of their first employees as the Vice President of Clinical, Regulatory and Quality Affairs and Chief Medical Officer. During his time there he managed the design, implementation and successful completion of the FIRE Clinical trial, an 800 patient pivotal study which led to the FDA clearance of the FilterWire EX(TM) Device. Previously, Milt was the President and Chief Executive Officer of Genitope, Inc. an early stage biotechnology company focusing on patient-specific therapies for lymphoma which eventually became publically traded; President and Chief Executive Officer of CSFluids, Inc. (later renamed Eunio), a development-stage company offering a surgical treatment for Alzheimer's Disease; Vice President of Regulatory Affairs, Quality Affairs, Clinical Affairs and Chief Medical Officer for Gynecare, Inc. (eventually acquired by Johnson and Johnson) and Director of Marketing for Origin Medsystems (acquired by Eli Lilly/Guidant Corporation).

Milt began his career as a professional football player with the San Francisco Forty-Niners and Los Angeles Raiders from 1981 to 1988. He was a member of two Super Bowl Championship teams for the Forty-Niners and was a special team's captain.

Milt earned a B.S. in Biology from Stanford University and his M.D. from Stanford University School of Medicine.

Board Seats: Compact Imaging, Gauss Surgical